Yaling Guo
- Epidemiology top 10%
- Infectious Diseases top 5%
- Nephrology top 5%
- Immunology
- Molecular Biology
- Topics
- Renal Diseases and Glomerulopathies (7 papers)COVID-19 Clinical Research Studies (4 papers)Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers)
In The Last Decade
Yaling Guo
27 papers receiving 740 citations
Peers
Comparison fields: 5 of 91
- Epidemiology 349
- Infectious Diseases 340
- Nephrology 94
- Immunology 90
- Molecular Biology 83
Countries citing papers authored by Yaling Guo
This map shows the geographic impact of Yaling Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaling Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaling Guo more than expected).
Fields of papers citing papers by Yaling Guo
This network shows the impact of papers produced by Yaling Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaling Guo. The network helps show where Yaling Guo may publish in the future.
Co-authorship network of co-authors of Yaling Guo
This figure shows the co-authorship network connecting the top 25 collaborators of Yaling Guo. A scholar is included among the top collaborators of Yaling Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaling Guo. Yaling Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 6 | |
| 5 | 3 | |
| 6 | 14 | |
| 7 | 4 | |
| 8 | 53 | |
| 9 | 40 | |
| 10 | 18 | |
| 11 | 48 | |
| 12 | 16 | |
| 13 | 12 | |
| 14 | 1 | |
| 15 | 36 | |
| 16 | 63 | |
| 17 | 153 | |
| 18 | 24 | |
| 19 | 1 | |
| 20 | 31 |
About Yaling Guo
Yaling Guo is a scholar working on Nephrology, Infectious Diseases and Cell Biology, having authored 30 papers that have together received 744 indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (7 papers), COVID-19 Clinical Research Studies (4 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers). The work is most often cited by research in Infectious Diseases (340 citations), Nephrology (94 citations) and Epidemiology (349 citations). Yaling Guo has collaborated with scholars based in China, Singapore and Australia. Frequent co-authors include Yiqiang Chen, Shouming Qin, Cong Wu, Ke Wang, Lijuan Yang, Ke Wang, Lei Liu, Einar Wilder‐Smith, Yuan Lü and Weijie Li. Their work appears in journals such as PLoS ONE, CHEST Journal and Fertility and Sterility.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.